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Objective: This prospective study performed to evaluate blood biomarkers alterations with 
administration of propofol for maintenance of anaesthesia during long oral and maxillofacial 
surgeries in order to estimate the risk of Propofol Infusion Syndrome (PRIS). This rare syndrome 
often would be happened in long duration or high dose infusion which is characterized by the 
combination of metabolic acidosis, acute bradycardia and/or asystole, and rhabdomyolysis and can 
be fatal. 
Methods: Patients undergoing maxillofacial surgeries (>3h) were the subjects of this quasi 
experimental prospective clinical trial study. Induction of anaesthesia was performed with 
midazolam 0.025 mg/kg, fentanyl 2 µg/kg, thiopental sodium 5 mg/kg, and atracurium 0.5 mg/kg. 
Infusion of propofol was initiated (100 µg/kg/min) for maintenance of anesthesia. Serum potassium 
level, creatine kinase, lactate and blood PH, were evaluated at baseline, and at 2, 4, 6 hours 
following the initiation of propofol infusion. Generalized estimating equation was used to evaluate 
the longitudinal changes for each of the evaluated biomarkers. The relation between the biomarkers 
and the following factors were appraised by using covariance linear (enter mode) regression  
analysis: age, gender, weight, administered dose of dexamethasone and epinephrine, duration of 
surgery, and a history of trauma prior to surgery. 
Results: A total of 55 participants, 31 women and 24 men, were studied. The mean duration of 
surgery was 4.8(1) hours. Despite the rise in the level of potassium and creatine kinase and the 
reduction of blood PH, no case of hyperkalemia or severe metabolic acidosis was observed. Serum 
lactate level gradually increased to higher than normal in few patients; though did not necessitate  
any intervention. All alterations were statistically significant. Potassium and creatine kinase level at 
baseline had relation to pre-surgical trauma. 
Conclusion: Maintenance of anaesthesia with 100 µg/kg/min propofol along with administration of 
low-dose epinephrine and dexamethasone did not cause clinically important alterations in blood 
biomarkers during long-duration maxillofacial surgeries and might not cause PRIS. 
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Propofol is an intravenous sedative-hypnotic 
agent, broadly used for induction and 
maintenance of general anaesthesia and inpatient 
sedation, as well as continuous sedation at 
intensive care units (ICU). The superiority  of 
this  medicine  over  other  anesthetic  agents   is 
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mainly due to its quick onset of action and rapid 
recovery of consciousness. Moreover, its 
minimal effect on blood pressure leading to 
reduced intra-operative bleeding makes it 
particularly advantageous for out- and in-patient 
oral and maxillofacial surgeries (1-4). 
Despite all the advantages, serious adverse 
effects such as refractory bradycardia, cardiac 
asystole, metabolic acidosis, and  
rhabdomyolysis have been reported with higher 
doses (>4mg/kg/h) or long-term (>48h) infusion 
of this agent (1, 4-6). A few cases have also 
demonstrated the occurrence of these symptoms 
with short term or low-dose infusions of  
propofol (7-11). These rarely seen but fatal 
symptoms, having been called the Propofol 
Infusion Syndrome (PRIS) since 1998 (5) and 
has resulted in debates regarding the safety of 
propofol in different medical settings. 
Although propofol has been proved as a safe and 
efficacious sedative agent for outpatient oral 
surgeries (1, 12-13), the probability of an 
increased risk of PRIS, still remains obscure, 
when propofol is used for maintenance of 
anaesthesia in long-duration oral and 
maxillofacial surgeries. Besides, the concomitant 
use of catecholamines and corticosteroids has 
been suggested as a risk factor for incidence of 
PRIS (4). 
Administration of these medicines is common in 
oral and maxillofacial surgeries for elimination 
of bleeding and inflammation, so raises concern 
about the safety of this anesthetic agent in 
maxillofacial surgeries. 
Metabolic derangements revealed by monitoring 
certain biochemical markers such as electrolytes, 
serum creatine kinase, serum lactate, and blood 
PH, that can serve as an early manifestations of 
PRIS (4,6). This prospective study aimed to 
evaluate the propofol-induced alterations  in 
these biochemical parameters during long oral 
and maxillofacial surgeries (>3h) and to 
determine the relationship between these  
changes and different durations of surgeries. 
Methods: 
 
This quasi-experimental clinical trial was in 
accordance with Helsinki Declaration and was 
approved by the ethical committee of Shahid 
Beheshti University of Medical Sciences. The 
study was performed on patients undergoing 
long-duration oral and maxillofacial surgeries in 
our teaching hospital, Tehran, Iran in 2011. 
Patients within 18-60 years of age who were a 
class I or II according to the American Society 
of Anaesthesiologists (ASA) physical 
status classification were enrolled in this study. 
The exclusion criteria were: history of drug 
abuse, allergies to egg and soya bean, history of 
respiratory and/or renal  disease,  surgical 
procedures lasting for less than 3 hours, severe 
hypotension during surgery, and malignant 
hyperthermia. Furthermore, patients who 
received blood transfusion or any medicine,  
other than those included in the treatment plan 
were also excluded. Written informed consent 
was obtained from each participant following 
explanation of the study process and aims. 
At surgery, patients were pre-medicated with 
midazolam 0.025 mg/kg, fentanyl 2 µg/kg, 
thiopental sodium 5 mg/kg, and atracurium 0.5 
mg/kg and were intubated at the bispectral index 
(BIS) of 40-60. Subsequently, infusion of 
propofol was initiated (100 µg/kg/min) in order 
to maintain the BIS reading at 40-60. Along with 
propofol infusion, all patients received IV bolus 
of dexamethasone (8 mg, repeated at 4 hour 
intervals by intravenous administration), as well 
as local Anaesthesia (lidocaine 2%, epinephrine 
1/100000 in 10 cc, administered subcutaneous). 
Remifentanil with dose of 0.05 µg/kg/min was 
used as analgesic agent. 
Heart rate, blood pressure, oxygen saturation 
(SPO2), end-tidal CO2 (ETCO2), and temperature 
were monitored from prior to induction of 
anaesthesia until the patient was transferred to 
recovery room. Evaluation of serum electrolyte 
level (including potassium level and blood  PH), 
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serum creatine kinase, and serum lactate was 
performed for all participants at baseline, and 
then at 2, 4, and 6 hours post-propofol infusion. 
The relation between the evaluated biomarkers 
and the following factors was also appraised: 
age, gender, body weight, administered dose of 
dexamethasone and epinephrine, duration of 
surgery, and a history of trauma prior to surgery. 
At the end of surgery, all patients were reversed 
by neostigmine 0.07 mg/kg and atropine 0.01 
mg/kg. All statistical analyses were performed 
using statistical package for the social sciences 
(SPSS) software, version 16. Quantitative data 
were presented by mean (standard deviation) 
while qualitative data were reported by 
frequencies and percentages. Generalized 
estimating equation with exchangeable 
correlation structure was used to evaluate the 
longitudinal changes for each of the studied 
biomarkers. To assess the effect of different 
factors on the measured biomarkers, covariance 
linear (enter mode) regression analysis was 
performed. The level of significance was defined 
as p-value less than 0.05. 
Results: 
 
A total of 67 patients were enrolled for oral and 
maxillofacial surgeries under general anaesthesia 
with duration of more than 3 hours, were 
enrolled in this study. Twelve patients required 
blood transfusion or infusion of tri-nitroglycerin 
(TNG) during the surgery, hence were excluded 
from the experiment. The remaining 55 
participants with an average age of 31.1 years  
old (SD=12.5, range 18-60 years old) consisted 
of 31 women (56.4%) and 24 men (43.6%) were 
followed until the end of this trial. The average 
body weight of the patients was 54.4 kg 
(SD=8.5, range 43-70 kg). The average duration 
of surgery was 4.8 hours (SD=1, range 3-6.5 
hours). Table 1 demonstrates the frequencies and 
percentages of different types of surgeries 
performed on the participants. The average 
amount of dexamethasone and epinephrine 
received by the patients during surgery was 10.5 
mg/kg  (SD=3.7,  range  8-16  mg/kg)  and  57.3 
µg/kg (SD=21.6, range 0-90µg/kg), respectively. 
Table 1- The frequencies and percentages of different types of surgeries performed on participants. 













In table 2 the average values for serum 
potassium, blood pH, serum creatine kinase, and 
serum lactate, measured at baseline and at 2, 4, 
and 6 hours during the surgery, is demonstrated. 
It should be noted that duration of surgery was 
less than 4 hours in 2 patients and less than 6 
hours in 38 patients. The level of potassium was 
increased (Diagram 1) and blood pH reduced 
(Diagram 2) after initiation of propofol infusion. 
Time had a significant effect on potassium level 
and blood pH, with a 0.034 mEq/L increment  
per hour and 0.012 decline per hour, respectively 
(p<0.001). Nevertheless, no case of 
hyperkalemia (potassium level> 5mEq/L) or 
severe metabolic acidosis (pH<7.3) was 
observed. Serum creatine kinase was also 
significantly increased after the initiation of 
propofol infusion, demonstrating an increase   of 
 patients  
Orthognathic surgery 14 25.5 
Recent trauma 7 12.7 
Previous trauma 4 7.3 
Aesthetic 12 21.8 
Condylectomy 3 5.5 
Bone grafting 4 7.3 
Pathologies 11 20 
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17.445 IU per hour Diagram3). 
 
Table 2- The average values for serum potassium, blood PH, serum creatine kinase, and serum lactate, 




At 2 h 
N=55 
At 4 h 
N=53 




 3.96 4.06 4.09 
(mEq/L) 
(SD=0.29) (SD=0.25) (SD=0.3) (SD=0.27) 
Range 3.4-4.8 3.4-4.5 3.5-4.8 3.5-4.5 
7.38 7.37 7.34 7.32 
PH 
Average 
(SD=0.06) (SD=0.09) (SD=0.09) (SD=0.07) 
Range 7.3-7.54 7.3-7.55 7.3-7.5 7.3-7.44 
Creatine 
Average
 76.5 114.2 144.4 191.2 
kinase (SD=32.5) (SD=39) (SD=61.3) (SD=57.6) 
(IU/L) Range 13-170 33.5-196 35-360 109-340 
Lactate Average
 8.69
 12.12 14.82 18.32 
(mg/dL) 
(SD=3.82) (SD=5.76) (SD=6.53) (SD=7.07) 
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114.2   Serum Creatine 
Kinase (IU/L) 
Base line Hour 2 Hour 4 Hour 6 
Time 
Diagram 3- Mean level of serum creatine kinase at different times of measurement 
 
Creatine kinase level was not increased to higher 
than the normal level (<240 IU/L) in any of the 
patients. On the other hand, the level of serum 
lactate gradually increased from the baseline 
level and reached to the levels higher than 19.8 
mg/dL in some patients (normal range in venous 
blood sample: 4.5-19.8 mg/dL); (Figure 4). This 
increase was statistically significant (1.555 
mg/dL increase per hour, p<0.001); however, it 
was not presented any clinically important 
manifestation in any of the patients and did not 
necessitate further intervention. Given these 
results, PRIS occurred in none of the participants 
who received propofol infusion with dose of 100 
µg/kg/min for more than three hours. 
According to the covariance regression analysis, 
serum potassium level at baseline was only 
relevantto trauma and was increased in traumatic 
patients (p=0.04). Moreover, potassium level  
was directly related to the duration of surgery 
within 2 hours post-infusion (p=0.042) and at 4 
hours post-infusion (p<0.001). 
Creatine kinase level at baseline was also related 
to trauma (p=0.029). In addition, creatine kinase 
level at 4 hours post-infusion was found to have 
a positive relation with the duration of surgery 
(p=0.008), while it was reduced by the increase 
of dexamethasone dose (p=0.035). 
Blood pH and serum lactate level had no 
significant relation with the factors considered 
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Our current knowledge about the etiology, risk 
factors, and diagnostic symptoms of PRIS is 
limited to the findings reported in case reports 
and retrospective studies, probably due to its rare 
incidence (14). Propofol infusions longer than 48 
h or with doses greater than 4 mg/kg/h are 
considered the major risk factors for PRIS (1,4- 
6) 
This rare syndrome would be happened in long 
duration and/or high dose propofol infusions 
which are characterized by the combination of 
metabolic acidosis, acute bradycardia and/or 
asystole with cardiac and renal failure and 
rhabdomyolysis which is often fatal (2, 4-6). 
This prospective study aimed to assess 
biomarker changes associated with propofol 
administration for maintenance of anaesthesia 
during long term oral and maxillofacial 
surgeries. Alterations in biomarker levels, 
although statistically significant, were not 
clinically important in any of the patients. None 
of our patients, in whom general anaesthesia was 
maintained with propofol for more than 3 hours, 
were affected with PRIS. 
So it seems close observation of the patient is  
the key to prevention of mortality associated  
with PRIS. Frequent monitoring of certain 
chemical biomarkers; even if not definite, has 
been recommended for early diagnosis of PRIS 
(15). Metabolic acidosis and an increase in blood 
lactate level are suggested as significant 
diagnostic indicators (14-15). These laboratory 
findings have mainly been reported in 
association with long durations of propofol 
infusion (15). Burow, et al. (2004) reported a 
patient in whom metabolic acidosis developed 
following high-dose propofol-induced 
anaesthesia (16). In the absence of other 
causative factors for metabolic acidosis,  
propofol was suggested as the potential cause. 
In the current study, blood PH decreased during 
the  surgery  but  remained  within  the     normal 
 
range. Therefore, metabolic acidosis did not 
occur in any of the patients. The declinein PH 
was presumed to be due to the traumatic nature 
of the surgeries. It has been suggested that 
trauma and subsequent reduction in tissue 
perfusion can lead to metabolic acidosis (17). In 
addition, in the present study the level of serum 
lactate gradually increased by time and went 
beyond the normal value. On the contrary, in a 
retrospective study which appraised arterial 
blood lactate in patients under propofol-based 
general Anaesthesia, lactic acidosis was not seen 
in any of the patients after 8 hours (18). 
Fudickar, et al. (2008) reported a case in which 
PRIS occurred while patient’s serum lactate was 
within the normal range (19). These findings 
might suggest lactic acidosis to be an unspecific 
marker for diagnosis of PRIS. Several factors 
can contribute to lactic acidosis; namely, tissue 
hypoxia, hyperventilation, inflammation, and 
surgical trauma (19, 20). In only a few patients  
in the present study serum lactate were increased 
almost twofold, requiring no  further 
intervention. 
Creatine kinase is another biomarker which has 
shown an increase in patients affected with PRIS 
(14, 15). In the current study, the level of serum 
creatine kinase was increased but did not pass  
the normal limits. A relation was found between 
the level of creatine kinase and trauma before 
surgery. Creatine kinase is an indicator of 
muscle necrosis and increases with trauma and 
surgery (14, 21). In addition, this study found a 
negative relation between the level of creatine 
kinase and administration of dexamethasone.  
The anti-inflammatory effects of dexamethasone 
might have reduced rhabdomyolysis, and so the 
subsequent release of creatine kinase in blood. 
Moreover, in this study we evaluated the level of 
serum potassium which demonstrated a mild 
increase during the surgery. Again,  
hyperkalemia was not detected in any of the 
participants. The increase in serum potassium 
level  was  also  found  to  be  related  to  trauma 
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before surgery. Mali, et al. (2009) observed 
hyperkalemia as an isolated sign of PRIS when 
short-term infusions of 3 mg/kg/h propofol were 
administered for anaesthesia (10). However, 
development of hyperkalemia can also be due to 
a sundry of reasons including administration of 
certain drugs, malignant hyperthermia, blood 
transfusion, and severe acidosis (10, 22). 
Epinephrine is commonly administered during 
oral and maxillofacial surgeries to provide 
hemostasis (13). This vasopressor agent has  
been introduced as one of the risk factors for 
occurrence of PRIS during propofol-induced 
anaesthesia/sedation (4). Several reports of PRIS 
are in cases with concomitant use of propofol 
and epinephrine (23, 24). A retrospective cohort 
study reported 3 occurrences of PRIS among 30 
patients, in intensive care units, who received 
propofol for sedative purposes (dosage, up to 
134µg/kg/min; for 86-135 hours) with 
catecholamine simultaneously (25). 
Corticosteroids such as dexamethasone have  
also been associated with an increased risk of 
PRIS (4). In the current study, relatively low 
doses of epinephrine and dexamethasone were 
administered during surgery (average dose of 
57.3µg/kg and 10.5mg/kg, respectively). 
To our knowledge, this is the first prospective 
study evaluating the biomarker changes 
associated with PRIS during oral and 
maxillofacial surgeries. The obtained results 
demonstrated that maintenance of anaesthesia 
with 100 µg/kg/min propofol along with 
administration of low-dose epinephrine and 
dexamethasone is anacceptable protocol for 
long-duration oral and maxillofacial surgeries. 
While alterations in chemical biomarkers did not 
 
appear to be a direct effect of propofol, precise 
monitoring of the patient is strongly 
recommended even when maintenance doses of 
propofol are to be used. 
It is not disputable that more precise results 
could have been accomplished if a controlled 
randomized design comparing propofol with 
another anaesthetic agent could be implemented 
in this study. However, according to the 
guidelines of our department, administration of 
other types of anesthetic agents for long term 
maintenance would not be ethically approved 
and also conducting classic randomized 
controlled trials are not possible in many  




Maintenance of anaesthesia with 100 µg/kg/min 
propofol along with administration of low-dose 
epinephrine and dexamethasone did not cause 
clinically important alterations in blood 
biomarkers during long-duration maxillofacial 
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